Trans American Aquaculture (GRPS) Enterprise Value (2023 - 2025)

Trans American Aquaculture (GRPS) reported Enterprise Value of -$509.0 for Q3 2025, down 157.07% quarter-over-quarter from -$198.0 in Q2 2025.

Trans American Aquaculture (GRPS) Enterprise Value (2023 - 2025) Analysis & Trends

Trans American Aquaculture has reported Enterprise Value for 2 years, with the latest figure at -$509.0 in Q3 2025.

For the quarter ending Q3 2025, Enterprise Value changed N/A year-over-year to -$509.0; the trailing twelve-month figure through Sep 2025 stood at -$509.0 (changed N/A YoY), and the FY2023 full-year result was -$6600.0, changed N/A from the prior year.
Enterprise Value for Q3 2025 stood at -$509.0, down from -$198.0 in the prior quarter.
The five-year high for Enterprise Value was -$198.0 in Q2 2025, with the low at -$31480.0 in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Enterprise Value (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn	-3.74 Bn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn	-1.94 Bn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	-2.15 Bn
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn	-77.77 Mn
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn	-1.32 Bn
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn	-428.00 Mn
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn	-511.86 Mn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn	-498.58 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn	-750.88 Mn
10	Trans American Aquaculture	-	-	-	-509.00

Download Data